FTXH vs. SMH
Compare and contrast key facts about First Trust Nasdaq Pharmaceuticals ETF (FTXH) and VanEck Vectors Semiconductor ETF (SMH).
FTXH and SMH are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. FTXH is a passively managed fund by First Trust that tracks the performance of the Nasdaq U.S. Smart Pharmaceuticals Index. It was launched on Sep 20, 2016. SMH is a passively managed fund by VanEck that tracks the performance of the MVIS US Listed Semiconductor 25 Index. It was launched on Dec 20, 2011. Both FTXH and SMH are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: FTXH or SMH.
Performance
FTXH vs. SMH - Performance Comparison
Returns By Period
In the year-to-date period, FTXH achieves a 6.76% return, which is significantly lower than SMH's 39.89% return.
FTXH
6.76%
-0.59%
6.44%
16.01%
6.33%
N/A
SMH
39.89%
-1.76%
0.15%
51.80%
33.24%
28.03%
Key characteristics
| FTXH | SMH | |
|---|---|---|
| Sharpe Ratio | 1.23 | 1.50 |
| Sortino Ratio | 1.75 | 2.01 |
| Omega Ratio | 1.22 | 1.26 |
| Calmar Ratio | 1.24 | 2.09 |
| Martin Ratio | 4.54 | 5.56 |
| Ulcer Index | 3.52% | 9.31% |
| Daily Std Dev | 13.01% | 34.44% |
| Max Drawdown | -32.11% | -95.73% |
| Current Drawdown | -4.86% | -13.03% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FTXH vs. SMH - Expense Ratio Comparison
FTXH has a 0.60% expense ratio, which is higher than SMH's 0.35% expense ratio.
Correlation
The correlation between FTXH and SMH is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
FTXH vs. SMH - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Nasdaq Pharmaceuticals ETF (FTXH) and VanEck Vectors Semiconductor ETF (SMH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
FTXH vs. SMH - Dividend Comparison
FTXH's dividend yield for the trailing twelve months is around 1.57%, more than SMH's 0.43% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FTXH First Trust Nasdaq Pharmaceuticals ETF | 1.57% | 1.56% | 1.10% | 1.03% | 0.82% | 0.67% | 0.92% | 2.18% | 0.19% | 0.00% | 0.00% | 0.00% |
SMH VanEck Vectors Semiconductor ETF | 0.43% | 0.60% | 2.37% | 1.02% | 1.38% | 6.00% | 3.75% | 2.85% | 1.61% | 4.28% | 2.31% | 3.11% |
Drawdowns
FTXH vs. SMH - Drawdown Comparison
The maximum FTXH drawdown since its inception was -32.11%, smaller than the maximum SMH drawdown of -95.73%. Use the drawdown chart below to compare losses from any high point for FTXH and SMH. For additional features, visit the drawdowns tool.
Volatility
FTXH vs. SMH - Volatility Comparison
The current volatility for First Trust Nasdaq Pharmaceuticals ETF (FTXH) is 5.46%, while VanEck Vectors Semiconductor ETF (SMH) has a volatility of 8.43%. This indicates that FTXH experiences smaller price fluctuations and is considered to be less risky than SMH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.